2-Deoxy-D-glucose (2-DG), the inhibitor of hexokinase, has been shown to promote autophagy, suppress apoptosis, and improve kidney function by enhancing SIRT3/AMPK pathway in LPS-induced AKI (Tan et al., 2021). The gene discussed is SIRT3; the disease is acute kidney injury.